Anxiety and mood disorders in narcolepsy: a case-control study

General Hospital Psychiatry

Volumn 32, Issue 1, 2010, Pages 49-56

  Fortuyn, H A Droogleever ^a   Lappenschaar, Martijn A ^a   Furer, Joop W ^a   Hodiamont, Paul P ^a,b   Rijnders, Cees A Th ^a,c   Renier, Willy O ^a,d   Buitelaar, Jan K ^a   Overeem, Sebastiaan ^a,e  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b TILBURG UNIVERSITY   (Netherlands)

^c Institute for Mental Health Care Breburg Group   (Netherlands)

^d CANISIUS WILHELMINA HOSPITAL   (Netherlands)

^e EPILEPSY CENTER KEMPENHAEGHE   (Netherlands)

Author keywords

Anxiety; Depression; Hypocretin; Mania; Mood; Orexin; Panic attacks; Phobia

Indexed keywords

ADULT; ANXIETY DISORDER; ARTICLE; CASE CONTROL STUDY; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MOOD DISORDER; NARCOLEPSY; PANIC; PREVALENCE; SCHEDULES FOR CLINICAL ASSESSMENT IN NEUROPSYCHIATRY; SEMI STRUCTURED INTERVIEW; SOCIAL PHOBIA;

ADULT; ANXIETY; CASE-CONTROL STUDIES; FEMALE; HUMANS; INTERVIEW, PSYCHOLOGICAL; MALE; MIDDLE AGED; MOOD DISORDERS; NARCOLEPSY; NETHERLANDS; PANIC DISORDER;

EID: 73549106552     PISSN: 01638343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.genhosppsych.2009.08.007     Document Type: Article

References (39)

1. Benca R.M., Obermeyer W.H., Thisted R.A., and Gillin J.C. Sleep and psychiatric disorders. A meta-analysis. Arch Gen Psychiatry 49 8 (1992) 651-668
2. Haba-Rubio J. Psychiatric aspects of organic sleep disorders. Dialogues Clin Neurosci 7 4 (2005) 335-346
3. Costa e Silva J.A. Sleep disorders in psychiatry. Metabolism 55 10 Suppl 2 (2006) S40-S44
4. Dauvilliers Y., Arnulf I., and Mignot E. Narcolepsy with cataplexy. Lancet 369 9560 (2007) 499-511
5. Overeem S., Scammell T.E., and Lammers G.J. Hypocretin/orexin and sleep: implications for the pathophysiology and diagnosis of narcolepsy. Curr Opin Neurol 15 6 (2002) 739-745
6. Fortuyn H.A., Swinkels S., Buitelaar J., et al. High prevalence of eating disorders in narcolepsy with cataplexy: a case-control study. Sleep 31 3 (2008) 335-341
7. Fortuyn H.A., Lappenschaar G.A., Nienhuis F.J., et al. Psychotic symptoms in narcolepsy: phenomenology and a comparison with schizophrenia. Gen Hosp Psychiatry 31 2 (2009) 146-154
8. Winsky-Sommerer R., Yamanaka A., Diano S., et al. Interaction between the corticotropin-releasing factor system and hypocretins (orexins): a novel circuit mediating stress response. J Neurosci 24 50 (2004) 11439-11448
9. Feng P., Vurbic D., Wu Z., Hu Y., and Strohl K.P. Changes in brain orexin levels in a rat model of depression induced by neonatal administration of clomipramine. J Psychopharmacol 22 7 (2008) 784-791
10. Allard J.S., Tizabi Y., Shaffery J.P., and Manaye K. Effects of rapid eye movement sleep deprivation on hypocretin neurons in the hypothalamus of a rat model of depression. Neuropeptides 41 5 (2007) 329-337
11. Dauvilliers Y.A., Paquereau J., Bastuji H., Drouot X., Weil J.S., and Viot-Blanc V. Psychological health in central hypersomnias: the French Harmony Study. J Neurol Neurosurg Psychiatry (2009)
12. Vourdas A., Shneerson J.M., Gregory C.A., et al. Narcolepsy and psychopathology: is there an association?. Sleep Med 3 4 (2002) 353-360
13. Kryger M.H., Walid R., and Manfreda J. Diagnoses received by narcolepsy patients in the year prior to diagnosis by a sleep specialist. Sleep 25 1 (2002) 36-41
14. American Academy of Sleep Medicine. The International Classification of Sleep Disorders, 2nd edition: diagnostic and coding manual (2005), American Academy of Sleep Medicine, Westchester (IL)
15. Hodiamont P.P., Rijnders C.A., Mulder J., and Furer J.W. Psychiatric disorders in a Dutch health area: a repeated cross-sectional survey. J Affect Disord 84 1 (2005) 77-83
16. Rijnders C.A., van den Berg J.F., Hodiamont P.P., et al. Psychometric properties of the Schedules for Clinical Assessment in Neuropsychiatry (SCAN-2.1). Soc Psychiatry Psychiatr Epidemiol 35 8 (2000) 348-352
17. Wing J.K., Babor T., Brugha T., et al. SCAN. Schedules for Clinical Assessment in Neuropsychiatry. Arch Gen Psychiatry 47 6 (1990) 589-593
18. Brugha T.S., Jenkins R., Taub N., Meltzer H., and Bebbington P.E. A general population comparison of the Composite International Diagnostic Interview (CIDI) and the Schedules for Clinical Assessment in Neuropsychiatry (SCAN). Psychol Med 31 6 (2001) 1001-1013
19. Kampman O., Kiviniemi P., Koivisto E., et al. Patient characteristics and diagnostic discrepancy in first-episode psychosis. Compr Psychiatry 45 3 (2004) 213-218
20. Baune B.T., Caniato R.N., Garcia-Alcaraz M.A., and Berger K. Combined effects of major depression, pain and somatic disorders on general functioning in the general adult population. Pain 138 2 (2008) 310-317
21. Sours J.A. Narcolepsy and other disturbances in the sleep-waking rhythm: a study of 115 cases with review of the literature. J Nerv Ment Dis 137 (1963) 525-542
22. Roy A. Psychiatric aspects of narcolepsy. Br J Psychiatry 128 (1976) 562-565
23. Baker T.L., Guilleminault C., Nino-Murcia G., and Dement W.C. Comparative polysomnographic study of narcolepsy and idiopathic central nervous system hypersomnia. Sleep 9 1 Pt 2 (1986) 232-242
24. Celestino D., Rosini E., Carucci M.L., Marconi P.L., and Vercillo E. Ménière's disease and anxiety disorders. Acta Otorhinolaryngol Ital 23 6 (2003) 421-427
25. Kales A., Soldatos C.R., Bixler E.O., et al. Narcolepsy-cataplexy: II. Psychosocial consequences and associated psychopathology. Arch Neurol 39 3 (1982) 169-171
26. Krishnan R.R., Volow M.R., Miller P.P., and Carwile S.T. Narcolepsy: preliminary retrospective study of psychiatric and psychosocial aspects. Am J Psychiatry 141 3 (1984) 428-431
27. Mosko S., Zetin M., Glen S., et al. Self-reported depressive symptomatology, mood ratings, and treatment outcome in sleep disorders patients. J Clin Psychol 45 1 (1989) 51-60
28. Daniels E., King M.A., Smith I.E., and Shneerson J.M. Health-related quality of life in narcolepsy. J Sleep Res 10 1 (2001) 75-81
29. Ervik S., Abdelnoor M., Heier M.S., Ramberg M., and Strand G. Health-related quality of life in narcolepsy. Acta Neurol Scand 114 3 (2006) 198-204
30. Dodel R., Peter H., Spottke A., et al. Health-related quality of life in patients with narcolepsy. Sleep Med 8 7-8 (2007) 733-741
31. Akechi T., Nakano T., Akizuki N., et al. Somatic symptoms for diagnosing major depression in cancer patients. Psychosomatics 44 3 (2003) 244-248
32. Koenig H.G., George L.K., Peterson B.L., and Pieper C.F. Depression in medically ill hospitalized older adults: prevalence, characteristics, and course of symptoms according to six diagnostic schemes. Am J Psychiatry 154 10 (1997) 1376-1383
33. Brundin L., Petersen A., Bjorkqvist M., and Traskman-Bendz L. Orexin and psychiatric symptoms in suicide attempters. J Affect Disord 100 1-3 (2007) 259-263
34. Shin H.S., Cho H.S., Sung K.W., and Yoon B.J. Orexin-A increases cell surface expression of AMPA receptors in the striatum. Biochem Biophys Res Commun 378 3 (2009) 409-413
35. 1 dopamine receptors in renewal of extinguished alcohol-seeking. Neuroscience 146 2 (2007) 525-536
36. Aston-Jones G., Smith R.J., Moorman D.E., and Richardson K.A. Role of lateral hypothalamic orexin neurons in reward processing and addiction. Neuropharmacology 56 Suppl 1 (2009) 112-121
37. Schneier F.R., Liebowitz M.R., bi-Dargham A., Zea-Ponce Y., Lin S.H., and Laruelle M. Low dopamine D(2) receptor binding potential in social phobia. Am J Psychiatry 157 3 (2000) 457-459
38. Mathew S.J., Coplan J.D., and Gorman J.M. Neurobiological mechanisms of social anxiety disorder. Am J Psychiatry 158 10 (2001) 1558-1567
39. Mathew S.J., Price R.B., and Charney D.S. Recent advances in the neurobiology of anxiety disorders: implications for novel therapeutics. Am J Med Genet C Semin Med Genet 148C 2 (2008) 89-98